Breaking News Instant updates and real-time market news.

MRK

Merck

$62.11

0.16 (0.26%)

08:09
06/14/18
06/14
08:09
06/14/18
08:09

Merck Q2 estimates lowered below consensus at Morgan Stanley

Morgan Stanley analyst David Risinger cut his Q2 revenue estimate for Merck by 1% to $10.1B, which he notes is below the consensus view of $10.3B, and lowered his Q2 EPS estimate by 6% to 97c. This is below the consensus view of $1.03, which he argues "needs to come down." The two key drivers were lowering his estimates for Keytruda in the U.S. due to a more gradual ramp in first-line lung cancer patients and the negative impact of hedging, which he sees being similar to, but less pronounced, than in Q1. He lowered his full-year EPS view by only 1%, however, which puts it 2% below consensus. Risinger keeps an Overweight rating and $68 price target on Merck shares.

  • 28

    Jun

  • 10

    Sep

  • 23

    Oct

MRK Merck
$62.11

0.16 (0.26%)

05/18/18
PIPR
05/18/18
NO CHANGE
Target $28
PIPR
Overweight
Eiger BioPharmaceuticals price target raised to $28 from $17 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Eiger BioPharmaceuticals (EIGR) to $28 after the company expanded its lonafarnib licensing agreement with Merck (MRK) for rights in ultra-orphan indication Hutchinson-Gilford Progeria syndrome. The analyst now anticipates FDA approval of lonafarnib in HGPS in 2020. He reiterates an Overweight rating on Eiger shares.
05/24/18
MZHO
05/24/18
NO CHANGE
Target $103
MZHO
Buy
Nektar is Bristol-Myers' best chance in immuno-oncology, says Mizuho
Nektar Therapeutics' (NKTR) NKTR-214 asset is the best shot Bristol-Myers Squibb (BMY) has to retain its footing in the competitive immuno-oncology space, Mizuho analyst Difei Yang tells investors in a research note. The analyst says that recent data in non-small cell lung cancer presented by Merck (MRK) on Keytruda saw the company jump ahead of Bristol's Opdivo in this key indication. Upcoming data of the Opdivo/NKTR-214 combo at ASCO on June 2 will be key on 100 patients across multiple indications, Yang contends. She believes Bristol stands at risk of losing significant market share in the growing immuno-oncology space. Ahead of the data, the analyst reiterates a Buy rating on Nektar with a $103 price target.
06/01/18
ROTH
06/01/18
NO CHANGE
Target $400
ROTH
Buy
Roth Capital ups Madrigal price target to $400, examines possible M&A scenarios
Roth Capital analyst Yasmeen Rahimi noted that Madrigal Pharmaceuticals' (MDGL) "impressive" NASH resolution results published yesterday resulted in the stock's value being pushed up to make it the highest among "purely NASH" companies. Among large pharma companies, Rahimi believes those with the strongest metabolic franchises, large R&D teams, and sales forces focused on endocrinologists, gastroenterologists, and hepatologists likely have eyes on NASH assets, listing Merck (MRK), AstraZeneca (AZN), Eli Lilly (LLY) and Novo Nordisk (NVO) as examples. The historical acquisition price for NASH assets ranges from $200M to $1.7B, but Rahimi argues that Madrigal "can set the highest NASH price tag yet," estimating a potential takeout valuation of $5.6B. Rahimi raised her price target on Madrigal shares to $400 from $210 and keeps a Buy rating on the stock.
06/13/18
MSCO
06/13/18
NO CHANGE
MSCO
HHS 'smoke signals' worth noting for drugmakers, says Morgan Stanley
After HHS Secretary Alex Azar spoke at a two-hour Senate hearing, Morgan Stanley analyst David Risinger noted that Azar suggested that U.S. drug pricing needs to move to a system without rebates and said payments from drugmakers to PBMs should be eliminated. In listing four HHS actions that could hurt manufacturers, Risinger pointed out that Azar said he is interested in removing 100% cap on Medicaid rebates; he would like to adjust the Part D protected drug classes so that plans can extract rebates from manufacturers; HHS wants to require manufacturers to disclose drug list prices in TV ads; and HHS is focused on transitioning Part B to lower-priced private sector management. In summary, the analyst said that for drugmakers there was "no fire, but smoke signals worth noting." Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).

TODAY'S FREE FLY STORIES

APTX

Aptinyx

$0.00

(0.00%)

20:45
06/20/18
06/20
20:45
06/20/18
20:45
Syndicate
Aptinyx 6.4M share IPO priced at $16.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

AVRO

AvroBio

$0.00

(0.00%)

20:44
06/20/18
06/20
20:44
06/20/18
20:44
Syndicate
AvroBio 5.25M share IPO priced at $19.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

TV

Televisa

$18.25

0.51 (2.87%)

20:43
06/20/18
06/20
20:43
06/20/18
20:43
Downgrade
Televisa rating change  »

Televisa downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

Cemex

$6.33

0.115 (1.85%)

20:42
06/20/18
06/20
20:42
06/20/18
20:42
Upgrade
Cemex rating change  »

Cemex upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PH

Parker-Hannifin

$164.49

0.74 (0.45%)

20:41
06/20/18
06/20
20:41
06/20/18
20:41
Downgrade
Parker-Hannifin rating change  »

Parker-Hannifin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMT

Kennametal

$37.44

1.11 (3.06%)

20:41
06/20/18
06/20
20:41
06/20/18
20:41
Downgrade
Kennametal rating change  »

Kennametal downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNT

Syntel

$34.07

0.65 (1.94%)

20:40
06/20/18
06/20
20:40
06/20/18
20:40
Downgrade
Syntel rating change  »

Syntel downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MGTA

Magenta Therapeutics

$0.00

(0.00%)

20:28
06/20/18
06/20
20:28
06/20/18
20:28
Syndicate
Magenta Therapeutics 6.667M share IPO priced at $15.00 »

The deal priced in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

XERS

Xeris Pharmaceuticals

$0.00

(0.00%)

20:26
06/20/18
06/20
20:26
06/20/18
20:26
Syndicate
Xeris Pharmaceuticals 5.7M share IPO priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

KR

Kroger

$26.21

0.21 (0.81%)

, DRI

Darden

$93.27

-1.34 (-1.42%)

20:25
06/20/18
06/20
20:25
06/20/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

KR

Kroger

$26.21

0.21 (0.81%)

DRI

Darden

$93.27

-1.34 (-1.42%)

CMC

Commercial Metals

$23.67

0.44 (1.89%)

PDCO

Patterson Companies

$22.54

0.07 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 21

    Jun

  • 21

    Jun

  • 28

    Jun

  • 10

    Jul

IIIV

i3 Verticals

$0.00

(0.00%)

20:24
06/20/18
06/20
20:24
06/20/18
20:24
Syndicate
i3 Verticals 6.65M share IPO priced at $13.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

KZR

Kezar Life Sciences

$0.00

(0.00%)

20:23
06/20/18
06/20
20:23
06/20/18
20:23
Syndicate
Kezar Life Sciences 5M share IPO priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

LPL

LG Display

$8.91

-0.015 (-0.17%)

20:08
06/20/18
06/20
20:08
06/20/18
20:08
Periodicals
LG Display discussing early retirement options for workers, Bloomberg reports »

LG Display is considering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGO

Eldorado Gold

$1.13

-0.02 (-1.75%)

20:05
06/20/18
06/20
20:05
06/20/18
20:05
Hot Stocks
Eldorado Gold provides update on Lamaque exploration and development »

Eldorado Gold is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, RSX

Market Vectors Russia ETF

$20.52

0.22 (1.08%)

19:43
06/20/18
06/20
19:43
06/20/18
19:43
Periodicals
Trump planning to meet with Russia's Putin in Europe next month, Bloomberg says »

Donald Trump and…

SPX

S&P 500

$0.00

(0.00%)

RSX

Market Vectors Russia ETF

$20.52

0.22 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEO

CNOOC

$163.48

2.345 (1.46%)

19:29
06/20/18
06/20
19:29
06/20/18
19:29
Periodicals
CNOOC to proceed with expansion in Canada's oil sands, Reuters reports »

CNOOC's Nexen Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$134.34

-1.815 (-1.33%)

19:14
06/20/18
06/20
19:14
06/20/18
19:14
Periodicals
Toyota to reduce marketing costs to fund new research, Reuters reports »

Toyota Motors has started…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$202.08

4.62 (2.34%)

, GOOG

Alphabet

$1,169.38

1.52 (0.13%)

19:06
06/20/18
06/20
19:06
06/20/18
19:06
Periodicals
FTC chair wants to explore market power of big internet firms, Reuters says »

New U.S. Federal Trade…

FB

Facebook

$202.08

4.62 (2.34%)

GOOG

Alphabet

$1,169.38

1.52 (0.13%)

GOOGL

Alphabet Class A

$1,183.83

5.54 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

RYAAY

Ryanair

$117.11

3.54 (3.12%)

19:01
06/20/18
06/20
19:01
06/20/18
19:01
Periodicals
IAG, Ryanair preparing EU legal challenge over air traffic strikes, FT reports »

IAG and Ryanair are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNED

Barnes & Noble Education

$6.78

0.3 (4.63%)

, MU

Micron

$58.97

-0.26 (-0.44%)

19:00
06/20/18
06/20
19:00
06/20/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Barnes…

BNED

Barnes & Noble Education

$6.78

0.3 (4.63%)

MU

Micron

$58.97

-0.26 (-0.44%)

SCS

Steelcase

$15.55

0.2 (1.30%)

LITE

Lumentum

$56.45

0.8 (1.44%)

HPQ

HP Inc.

$23.31

-0.215 (-0.91%)

THO

Thor Industries

$104.81

6.5 (6.61%)

GLW

Corning

$28.40

0.015 (0.05%)

AOBC

American Outdoor Brands

$13.22

0.13 (0.99%)

LMNR

Limoneira

$26.65

0.63 (2.42%)

VERI

Veritone

$21.52

-0.64 (-2.89%)

TRUP

Trupanion

$41.07

0.8 (1.99%)

ARRS

Arris

$25.51

0.015 (0.06%)

WIX

Wix.com

$107.70

1.15 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 21

    Jun

  • 22

    Jun

  • 09

    Jul

  • 10

    Jul

  • 11

    Jul

  • 12

    Jul

  • 21

    Jun

  • 21

    Jun

  • 21

    Jun

DIS

Disney

$107.28

1.08 (1.02%)

18:55
06/20/18
06/20
18:55
06/20/18
18:55
Periodicals
Disney puts future 'Star Wars' spinoffs on hold, Collider reports »

Disney's Lucasfilm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

SPY

SPDR S&P 500 ETF Trust

$276.00

0.52 (0.19%)

, SPX

S&P 500

$0.00

(0.00%)

18:54
06/20/18
06/20
18:54
06/20/18
18:54
Periodicals
Trump sees U.S. quarterly GDP going much higher, Bloomberg reports »

Says the head of U.S.…

SPY

SPDR S&P 500 ETF Trust

$276.00

0.52 (0.19%)

SPX

S&P 500

$0.00

(0.00%)

X

U.S. Steel

$35.72

0.56 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,169.38

1.52 (0.13%)

, GOOGL

Alphabet Class A

$1,183.83

5.54 (0.47%)

18:51
06/20/18
06/20
18:51
06/20/18
18:51
Hot Stocks
Senators Cotton, Rubio urge Google to reconsider work with Huawei »

Senator Tom Cotton along…

GOOG

Alphabet

$1,169.38

1.52 (0.13%)

GOOGL

Alphabet Class A

$1,183.83

5.54 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

YTRA

Yatra

$7.14

-0.04 (-0.56%)

18:48
06/20/18
06/20
18:48
06/20/18
18:48
Syndicate
Yatra files to sell 8.5M ordinary shares »

Citigroup and Jefferies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOA

North American Energy

$5.70

0.05 (0.88%)

18:04
06/20/18
06/20
18:04
06/20/18
18:04
Hot Stocks
North American Construction Group awarded $160M contract from oil sands customer »

North American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.